LC
TIL icon

Lindbrook Capital’s Instil Bio TIL Stock Holding History

Lindbrook Capital’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.18K Hold
68
– – ﹤0.01% 2417
2024
Q4 		$1.3K Hold
68
– – ﹤0.01% 2429
2024
Q3 		$4.58K Hold
68
– – ﹤0.01% 2048
2024
Q2 		$700 Hold
68
– – ﹤0.01% 2548
2024
Q1 		$734 Hold
68
– – ﹤0.01% 2468
2023
Q4 		$518 Sell
68
-1
-1% -$7 ﹤0.01% 2572
2023
Q3 		$586 Hold
69
– – ﹤0.01% 2509
2023
Q2 		$755 Hold
69
– – ﹤0.01% 2423
2023
Q1 		$905 Hold
69
– – ﹤0.01% 2473
2022
Q4 		$863 Sell
69
-12
-15% -$593 ﹤0.01% 2491
2022
Q3 		$8K Buy
81
+12
+17% +$1.37K ﹤0.01% 1452
2022
Q2 		$6K Hold
69
– – ﹤0.01% 1498
2022
Q1 		$15K Hold
69
– – ﹤0.01% 1136
2021
Q4 		$23K Buy
+69
New +$26.6K ﹤0.01% 980

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Lindbrook Capital's TIL Position: Q1 2025 in Review

Lindbrook Capital held its Instil Bio (TIL) position steady in Q1 2025 at 68 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2417.

Lindbrook Capital first reported a position in TIL in Q4 2021 and has held it in 14 quarters since. The position peaked at $23K in Q4 2021. 43 funds tracked by Wall St. Rank hold TIL as of Q1 2025.

  • Lindbrook Capital held 68 shares of Instil Bio worth $1.18K as of Q1 2025.
  • Lindbrook Capital left its Instil Bio share count unchanged in Q1 2025.
  • Instil Bio made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2417 holding.
  • Lindbrook Capital first reported a position in Instil Bio in Q4 2021 and has held it in 14 quarters since.
  • Lindbrook Capital's Instil Bio position peaked at $23K in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Instil Bio as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.